title: Response to "Hepatitis C virus, sickle cell disease treatment options"--a February letter to the editor.
authors.forename: Duane T
authors.initials: DT
authors.lastname: Smoot
mesh_terms: D000755:Anemia, Sickle Cell / Q000453:epidemiology* / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D015897:Comorbidity; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D007372:Interferons; D007502:Iron Chelating Agents / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D007502:Iron Chelating Agents; D012254:Ribavirin; D007372:Interferons